Published in Am J Transplant on September 14, 2007
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology (2008) 4.26
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol (2011) 3.36
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl (2014) 3.11
Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria. Ann Surg (2016) 2.05
HCC patients suffer less from geographic differences in organ availability. Am J Transplant (2013) 1.52
Liver resection and transplantation in hepatocellular carcinoma. Liver Cancer (2012) 1.24
Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol (2012) 1.21
Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg (2011) 1.19
The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations. J Clin Exp Hepatol (2014) 1.12
Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China. J Cancer Res Clin Oncol (2009) 1.12
Updates in the management of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) (2011) 1.07
Recent advances in the surgical treatment of hepatocellular carcinoma. World J Gastroenterol (2014) 1.06
HCC: current surgical treatment concepts. Langenbecks Arch Surg (2012) 1.03
Treating rheumatic patients with a malignancy. Arthritis Res Ther (2011) 1.03
Staging systems of hepatocellular carcinoma: a review of literature. World J Gastroenterol (2014) 1.02
Diagnosis and treatment of hepatocellular carcinoma: An update. World J Hepatol (2015) 1.02
Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies. Liver Cancer (2012) 0.99
The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol (2008) 0.95
New advances in hepatocellular carcinoma. World J Hepatol (2016) 0.91
Circulating tumor cells measurements in hepatocellular carcinoma. Int J Hepatol (2012) 0.91
Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma. World J Gastroenterol (2011) 0.90
Hepatocellular Carcinoma and Liver Transplantation: State of the Art. J Clin Transl Hepatol (2014) 0.90
Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era. Dig Dis Sci (2011) 0.88
The management of patients awaiting liver transplantation. Nat Rev Gastroenterol Hepatol (2009) 0.86
Liver transplantation for hepatocellular carcinoma. World J Gastroenterol (2009) 0.86
Current status of therapy for hepatocellular carcinoma. Therap Adv Gastroenterol (2009) 0.84
Milan Criteria and UCSF Criteria: A Preliminary Comparative Study of Liver Transplantation Outcomes in the United States. Int J Hepatol (2012) 0.84
Management of hepatocellular carcinoma: Enlightening the gray zones. World J Hepatol (2013) 0.83
How grim is hepatocellular carcinoma? Ann Med Surg (Lond) (2014) 0.83
Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation. World J Gastroenterol (2014) 0.82
Liver Transplantation for HCC: A Review. Indian J Surg (2011) 0.82
Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria. World J Surg (2013) 0.82
Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol (2015) 0.82
MRI of hepatocellular carcinoma: an update of current practices. Diagn Interv Radiol (2014) 0.81
Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun. Surg Today (2016) 0.81
Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review. Gastrointest Cancer Res (2012) 0.80
Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence. Ann Gastroenterol (2015) 0.79
Medical treatment of hepatocellular carcinoma. Mediterr J Hematol Infect Dis (2009) 0.79
Liver transplantation for hepatocellular carcinoma: past, present and future. Middle East J Dig Dis (2013) 0.79
Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future. World J Hepatol (2016) 0.78
Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5. Clin Transplant (2015) 0.78
Current Treatment Approaches to HCC with a Special Consideration to Transplantation. J Transplant (2016) 0.78
Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation. World J Gastroenterol (2014) 0.78
Selection Criteria and Current Issues in Liver Transplantation for Hepatocellular Carcinoma. Liver Cancer (2016) 0.78
Up-to-seven criteria for hepatocellular carcinoma liver transplantation: a single center analysis. World J Gastroenterol (2013) 0.78
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol (2017) 0.78
The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer. Ann Surg Oncol (2016) 0.77
Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study. Dis Markers (2015) 0.77
Bridging to liver transplantation in HCC patients. Langenbecks Arch Surg (2017) 0.76
Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot". Transplantation (2017) 0.76
A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma. Surg Today (2016) 0.76
Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation. Oncotarget (2016) 0.76
Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation. World J Gastroenterol (2016) 0.76
Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant. JAMA Oncol (2016) 0.75
Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria. World J Hepatol (2016) 0.75
Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization. Mod Pathol (2016) 0.75
Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome. ISRN Hepatol (2014) 0.75
De novo Hepatocellular Carcinoma after Liver Transplantation. J Clin Transl Hepatol (2015) 0.75
Liver transplantation for small hepatocellular carcinoma. Hepatobiliary Surg Nutr (2016) 0.75
Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma. PLoS One (2015) 0.75
Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma. Transl Gastroenterol Hepatol (2016) 0.75
Preoperative portal venous and hepatic arterial embolization of tumor. Semin Intervent Radiol (2008) 0.75
How I do it: triaging patients with hepatocellular carcinoma. Semin Intervent Radiol (2012) 0.75
Liver transplantation for advanced hepatocellular carcinoma. Clin Mol Hepatol (2016) 0.75
Milan criteria and its expansions in liver transplantation for hepatocellular carcinoma. Hepatobiliary Surg Nutr (2016) 0.75
Validation of a criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation. Sci Rep (2015) 0.75
Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine. Organogenesis (2014) 0.75
HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations? Visc Med (2016) 0.75
Limitations of predicting microvascular invasion in patients with hepatocellular cancer prior to liver transplantation. Sci Rep (2017) 0.75
Recurrence of hepatocellular carcinoma after living donor liver transplantation: what is the current optimal approach to prevent recurrence? World J Surg (2011) 0.75
Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis. J Am Coll Surg (2017) 0.75
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19
An urgent remedy needed. Br Dent J (1991) 5.42
Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med (1987) 4.08
The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med (1999) 4.03
Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg Infect Dis (1997) 4.02
"Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet (1994) 3.33
Patient, center and geographic characteristics of nationally placed livers. Am J Transplant (2012) 3.16
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Differentiating human from animal isolates of Cryptosporidium parvum. Emerg Infect Dis (1999) 2.89
Patent foramen ovale in young stroke patients. Lancet (1988) 2.68
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50
Molecular characterization of Cryptosporidium isolates obtained from human immunodeficiency virus-infected individuals living in Switzerland, Kenya, and the United States. J Clin Microbiol (2000) 2.32
Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J Intern Med (2013) 2.22
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18
Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology (1992) 2.09
Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg (2000) 2.09
Variation in Cryptosporidium: towards a taxonomic revision of the genus. Int J Parasitol (1999) 2.07
Ligandin heterogeneity : evidence that the two non-identical subunits are the monomers of two distinct proteins. Biochim Biophys Acta (1977) 2.03
Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant (2013) 2.02
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Quantifying the risk of incompatible kidney transplantation: a multicenter study. Am J Transplant (2014) 2.00
Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res (2001) 1.97
Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology (1993) 1.92
Dental notations. Br Dent J (2000) 1.91
A comparison of Cryptosporidium subgenotypes from several geographic regions. J Eukaryot Microbiol (2001) 1.86
Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am J Physiol Lung Cell Mol Physiol (2007) 1.82
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol (1995) 1.82
Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology (1995) 1.81
Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med (1992) 1.80
Phylogenetic relationships of Cryptosporidium parasites based on the 70-kilodalton heat shock protein (HSP70) gene. Appl Environ Microbiol (2000) 1.76
Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet (1992) 1.63
A population genetic study of the Cryptosporidium parvum human genotype parasites. J Eukaryot Microbiol (2001) 1.63
A randomized trial of exercise and dietary counseling after liver transplantation. Am J Transplant (2006) 1.61
Liver transplantation in a patient with protoporphyria. Gastroenterology (1989) 1.60
Novel role for JNK as a stress-activated Bcl2 kinase. J Biol Chem (2001) 1.60
Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med (1991) 1.58
Molecular and phylogenetic characterisation of Cryptosporidium from birds. Int J Parasitol (2001) 1.55
Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther (1997) 1.55
The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States. JAMA (1992) 1.54
Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol (2001) 1.52
Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg (1996) 1.51
Influence of donor age on graft survival after liver transplantation--United Network for Organ Sharing Registry. Liver Transpl Surg (1995) 1.51
Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett (2000) 1.51
Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast. Ann Intern Med (2000) 1.43
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation (1995) 1.43
Pelvic floor physiology in women with faecal incontinence and urinary symptoms. Br J Surg (1995) 1.41
Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology (1992) 1.41
A modified vascular "sleeve" anastomosis for rearterialization in orthotopic liver transplantation in rats. Transplantation (1992) 1.40
United Network for Organ Sharing center-specific data: our report card. Liver Transpl Surg (1996) 1.39
Evaluation of Cryptosporidium parvum genotyping techniques. Appl Environ Microbiol (1999) 1.38
Reversal of chronic rejection after treatment failure with FK506 and RS61443. Transplantation (1993) 1.38
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection. J Hepatol (2000) 1.38
Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology (1994) 1.37
An outbreak of cryptosporidiosis linked to a foodhandler. J Infect Dis (2000) 1.37
Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res (2012) 1.37
Genotype and subtype analyses of Cryptosporidium isolates from dairy calves and humans in Ontario. Parasitol Res (2006) 1.37
Function and regulation of hepatic and intestinal fatty acid binding proteins. Chem Phys Lipids (1985) 1.36
Real-time PCR for the detection of Cryptosporidium parvum. J Microbiol Methods (2001) 1.32
Molecular epidemiology of cryptosporidiosis outbreaks and transmission in British Columbia, Canada. Am J Trop Med Hyg (1999) 1.30
Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol (1987) 1.30
Left atrial myxoma diagnosed by echocardiography, with observations on tumour movement. Br Heart J (1973) 1.28
Cloning of a cDNA encoding rat intestinal fatty acid binding protein. Proc Natl Acad Sci U S A (1984) 1.28
Liver transplantation for fulminant hepatic failure. Arch Surg (1993) 1.23
Liver transplantation for severe Amanita phalloides mushroom poisoning. Am J Surg (1990) 1.23
Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol (2001) 1.22
Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Am J Transplant (2008) 1.21
Functions of fatty acid binding proteins. Experientia (1990) 1.21
Solid-state NMR investigation of the dynamics of the soluble and membrane-bound colicin Ia channel-forming domain. Biochemistry (2001) 1.21
Detection of the Cryptosporidium parvum "human" genotype in a dugong (Dugong dugon). J Parasitol (2000) 1.21
Cryptosporidium canis n. sp. from domestic dogs. J Parasitol (2001) 1.20
Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther (1992) 1.19
Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology (1996) 1.19
Anatomical landmarks of the inguinal canal in prepubescent children. Aust N Z J Surg (1997) 1.18
Report of a consensus conference on transplant program quality and surveillance. Am J Transplant (2012) 1.18
Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology (1996) 1.17
Multiple endocrine adenomatosis type IIb. Diagnosis and treatment. JAMA (1975) 1.17
Long-term complications of living donor liver transplantation. Liver Transpl (2000) 1.16
Nuclear magnetic resonance imaging of experimentally induced liver disease. Radiology (1983) 1.16
A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg (1985) 1.15